Rulonilimab, a human IgG1 monoclonal antibody, selectively targets and binds to the programmed death-1 (PD-1) receptor, effectively inhibiting its interaction with PD-L1 and PD-L2. This inhibition disrupts downstream signaling pathways, thereby enhancing T-cell function and potentially exerting robust anti-tumor activity through immune checkpoint blockade. This antibody is designed for use in research focused on cancer immunotherapy and the modulation of immune responses.
Rulonilimab, a human IgG1 monoclonal antibody, selectively targets and binds to the programmed death-1 (PD-1) receptor, effectively inhibiting its interaction with PD-L1 and PD-L2. This inhibition disrupts downstream signaling pathways, thereby enhancing T-cell function and potentially exerting robust anti-tumor activity through immune checkpoint blockade. This antibody is designed for use in research focused on cancer immunotherapy and the modulation of immune responses.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
